Epidemiology of acute bacterial meningitis in adult patients in France;Actualisation de l'épidémiologie des méningites bactériennes aiguës chez l'adulte en France

Medecine et Maladies Infectieuses

Volumn 39, Issue 7-8, 2009, Pages 432-444

  Varon, E ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Antibiotic resistance; Listeria monocytogenes; Meningitis; Neisseria meningitidis; Streptococcus pneumoniae

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; FOSFOMYCIN; LEVOFLOXACIN; MENINGITIS VACCINE; MOXIFLOXACIN; PENICILLIN BINDING PROTEIN; RIFAMPICIN; VANCOMYCIN;

ACUTE DISEASE; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG INDICATION; FRANCE; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTION CONTROL; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; PNEUMOCOCCAL MENINGITIS; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; FRANCE; HUMANS; INCIDENCE; MENINGITIS, BACTERIAL; MENINGITIS, MENINGOCOCCAL; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PNEUMOCOCCAL INFECTIONS;

EID: 68049127928     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.02.034     Document Type: Review

References (60)

1. Goossens H., Ferech M., Coenen S., Stephens P., and European surveillance of antimicrobial consumption project group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 44 (2007) 1091-1095 [Erratum in: Clin Infect Dis 2007;44:1259]
2. Lexau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294 (2005) 2043-2051
3. Centers for disease control and prevention (CDC). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction - eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 57 (2008) 144-148
4. Le réseau Epibac. Surveillance des infections invasives à Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus pneumoniae, Streptococcus agalactiae (B) et Streptococcus pyogenes (A) en France métropolitaine Avec les laboratoires hospitaliers du réseau. http://www.invs.sante.fr/surveillance/epibac/default.htm.
5. Parent du Châtelet I., Taha M.K., Lepoutre A., and Lévy-Bruhl D. Les infections invasives à méningocoque en France en 2006. Bull Epidemiol Hebd 51-52 (2007) 437-441
6. Parent du Châtelet I., Taha M.K., Sesboüé C., Rouaud P., Perrocheau A., and Lévy-Bruhl D. Increased incidence of invasive meningococcal disease in Seine-Maritime. The evolving epidemiology due to the B:14:P1.7,16 strain. Arch Pediatr 14 (2007) 537-540
7. InVS, CIRE de Haute-Normandie, CNR des méningocoques, Dass de Seine-Maritime. Situation épidémiologique des infections invasives à méningocoques (IIM) dans le département de Seine-Maritime et dans la zone de Dieppe au 3 février 2008, http://www.invs.sante.fr.
8. Taha MK, Alonso JM. Données du centre national de référence des méningocoques.
9. European Union invasive bacterial infections surveillance network. Neisseria meningitidis surveillance network 2003-2004 report. www.euibis.org.
10. Zarantonelli M.L., Lancellotti M., Deghmane A.E., Giorgini D., Hong E., Ruckly C., et al. Hyperinvasive genotypes of Neisseria meningitidis in France. Clin Microbiol Infect (2008) 14:467-72. [Epub 2008]
11. Pace D., and Pollard A.J. Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines. Arch Dis Child 92 (2007) 909-915
12. Taha MK, Zarantonelli ML, Alonso JM, et al. Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks. Vaccine 2007;25:2537-8. [Epub 2006].
13. Bjune G., Hoiby E.A., Gronnesby J.K., et al. Effect of outer membrane vesicle vaccines against group B meningococcal disease in Norway. Lancet 38 (1991) 1093-1096
14. Holst J., Feiring B., Fuglesang J.E., et al. Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease. Vaccine 21 (2003) 734-737
15. Direction générale de la santé. Circulaire du 8 juin 2006 relatif à la prophylaxie des infections invasives à méningocoque B:14:P1.7,16.
16. Geslin P, centre national de référence des pneumocoques. Rapport d'activité 1997.
17. Varon E, Gutmann L, centre national de référence des pneumocoques. Rapport d'activité 2007. Epidemiologie 2006. http://www.invs.sante.fr/surveillance, rubrique centres nationaux de référence.
18. Karlowsky J.A., Jones M.E., Draghi D.C., and Sahm D.F. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime. Antimicrob Agents Chemother 47 (2003) 3155-3160
19. Hakenbeck R., Kaminski K., König A., van der Linden M., Paik J., Reichmann P., et al. Penicillin-binding proteins in (-lactam-resistant Streptococcus pneumoniae. Microb Drug Resist 5 (1999) 91-99
20. Sibold C., Henrichsen J., Konig A., Martin C., Chalkley L., and Hakenbeck R. Mosaic pbpX genes of major clones of penicillin-resistant Streptococcus pneumoniae have evolved from pbpX genes of a penicillin-sensitive Streptococcus oralis. Mol Microbiol 12 (1994) 1013-1023
21. Hakenbeck R., Konig A., Kern I., van Der Linden M., Keck W., Billot-Klein D., et al. Acquisition of five high-Mr penicillin-binding protein variants during transfer of high-level beta-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae. J Bacteriol 180 (1998) 1831-1840
22. Smith A.M., and Klugman K.P. Alteration in PBP 1A essential for high-level penicillin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 42 (1998) 1329-1333
23. Doit C., Loukil C., Fitoussi F., Geslin P., and Bingen E. Emergence in France of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin. Antimicrob Agents Chemother 43 (1999) 1480-1483
24. Du Plessis M., Bingen E., and Klugman K. Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin. Antimicrob Agents Chemother 46 (2002) 2349-2357
25. Kosowska K., Jacobs M.R., Bajaksouzian S., Koeth L., and Appelbaum P.C. Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs. Antimicrob Agents Chemother 48 (2004) 4020-4022
26. Sifaoui F., Kitzis M.D., and Gutmann L. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral beta-lactam antibiotics is associated with alterations of PBP2x. Antimicrob Agents Chemother 40 (1996) 152-156
27. Figueiredo A.M., Connor J.D., Sevrin A., Vaz Pato M.V., and Tomasz A. A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob Agents Chemother 36 (1992) 886-889
28. Recommandations 2007 du Comité de l'antibiogramme de la société française de microbiologie ; http://www.sfm.asso.fr.
29. European antimicrobial resistance surveillance system. Annual report 2006. http://www.earss.rivm.nl/.
30. Oteo J., Lazaro E., de Abajo F.J., Baquero F., Campos J., and Spanish members of the european antimicrobial resistance surveillance system. Trends in antimicrobial resistance in 1968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates. J Clin Microbiol 42 (2004) 5571-5577
31. Decousser J.W., Pina P., Viguier F., Picot F., Courvalin P., Allouch P., et al. Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob Agents Chemother 48 (2004) 3636-3639
32. Bingen E., Levy C., Varon E., de La Rocque F., Boucherat M., d'Athis P., et al. Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur J Clin Microbiol Infect Dis 27 (2008) 191-199 [Epub 2007 Nov 30]
33. Dubos F., Marechal I., Husson M.O., Courouble C., Aurel M., Martinot A., et al. Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France. Arch Dis Child 92 (2007) 1009-1012 [Epub 2007 Jul 11]
34. Lepoutre A, Varon E, Georges S, Gutmann L, Lévy-Bruhl D et les microbiologistes du réseau Epibac et du réseau des observatoires régionaux du pneumocoque. Impact de la vaccination par le vaccin pneumococcique conjugué heptavalent sur l'incidence des infections invasives à pneumocoque en France. Première analyse des données 2006. http://www.invs.sante.fr/surveillance/index.htm.
35. Pantosti A., Gherardi G., Conte M., Faella F., Dicuonzo G., and Beall B. A novel, multiple drug-resistant, serotype 24F strain of Streptococcus pneumoniae that caused meningitis in patients in Naples, Italy. Clin Infect Dis 35 (2002) 205-208
36. Beall B., McEllistrem M.C., Gertz R.E., Boxrud D.J., Besser J.M., Harrison L.H., et al. Emergence of a novel penicillin-non susceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States. J Infect Dis 186 (2002) 118-122
37. Porat N., Arguedas A., Spratt B.G., Trefler R., Brilla E., Loaiza C., et al. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes nor present in the antipneumococcal conjugate vaccine. J Infect Dis 190 (2004) 2154-2161
38. Hicks L.A., Harrison L.H., Flannery B., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196 (2007) 1346-1354
39. Hanage W.P. Serotype replacement in invasive pneumococcal disease: where do we go from where?. J Infect Dis 196 (2007) 1282-1284
40. Gaudelus J., Cohen R., and Hovart J. Couverture vaccinale du vaccin pneumococcique heptavalent conjugué en 2007, comparaison avec les années précédentes et les autres vaccins pédiatriques : analyse des carnets de santé. Med Enfance (2007) 1-4
41. Le Monnier A. Rapport annuel d'activité du centre national de référence des Listeria, 2006. http://www.pasteur.fr/recherche/RAR/RAR2006/Listeria.html.
42. Goulet V, Hedberg C, Le Monnier A, de Valk H. Increasing incidence of listeriosis in France and other European countries. Emerg Infect Dis 2008;14:734-40.
43. Perrocheau A., De Benoist Ac, Six C., Goulet V., Decludt B., and Levy-Brühl D. Épidémiologie des méningites bactériennes en France en 1999. Ann Med Intern 153 (2002) 311-317
44. Grayo S, Join-Lambert O, Desroches MC, Le Monnier A. Comparison of the in vitro efficacies of moxifloxacin and amoxicillin against Listeria monocytogenes. Antimicrob Agents Chemother. 2008;52:1697-702. [Epub 2008].
45. Join-Lambert O., and Khayal S. Listeria monocytogenes. In: Bingen E., Leclercq R., and Courvalin P. (Eds). Antibiogramme (2006), Éditions ESKA, Paris 365-370 p
46. Charpentier E., and Courvalin P. Emergence of the trimethoprim resistance gene dfrD in Listeria monocytogenes BM4293. Antimicrob Agents Chemother 41 (1997) 1134-1136
47. Godreuil S., Galimand M., Gerbaud G., Jacquet C., and Courvalin P. Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob Agents Chemother 47 (2003) 704-708
48. Poyart C. Données 2006 du centre national de référence des streptocoques.
49. Dabernat H. Centre national de référence pour Haemophilus influenzae. Rapport d'activité 2005. http://www.invs.sante.fr/surveillance/cnr/default.htm.
50. Johnson D.M., Sader H.S., Fritsche T.R., Biedenbach D.J., and Jones R.N. Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 47 (2003) 373-376
51. Ubukata K., Shibasaki Y., Yamamoto K., Chiba N., Hasegawa K., Takeuchi Y., et al. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 45 (2001) 1693-1699
52. Dabernat H., Delmas C., Seguy M., Pelissier R., Faucon G., Bennamani S., et al. Diversity of ß-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 46 (2002) 2208-2218
53. Dabernat H., Seguy M., and Delmas C. Activité de 9 (-F280 souches d'Haemophilus influenzae résistantes à l'ampicilline par bêta-lactamases et mécanisme non enzymatique. Med Mal Infect 32 (2002) 299-306
54. Osaki Y., Sanbongi Y., Ishikawa M., Kataoka H., Suzuki T., Maeda K., et al. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob Agents Chemother 49 (2005) 2834-2839
55. Hasegawa K., Chiba N., Kobayashi R., Murayama S.Y., Iwata S., Sunakawa K., et al. Rapidly increasing prevalence of ß-lactamase-non producing, ampicillin-resistant Haemophilus influenzae Type b in patients with meningitis. Antimicrob Agents Chemother 48 (2004) 1509-1514
56. Kaczmarek F.S., Gootz T.D., Dib-Hajj F., Shang W., Hallowell S., and Cronan M. Genetic and molecular characterization of ß-lactamase-negative ampicillin-resistant Haemophilus with unusually high resistance to ampicillin. Antimicrob Agents Chemother 48 (2004) 1630-1639
57. van de Beek D., de Gans J., Spanjaard L., Weisfelt M., Reitsma J.B., and Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351 (2004) 1849-1859 [Erratum in: N Engl J Med 2005;352:950]
58. Zoons E, Weisfelt M, de Gans J, Spanjaard L, Koelman JH, Reitsma JB, et al. Seizures in adults with bacterial meningitis. Neurology 2008;70:2109-15. [Epub 2008].
59. Dabernat H., Stahl J., Goulet V., et al. Méningites bactériennes en France. Étude dans six départements métropolitains en 1995-1997. Med Mal Infect 30 (2000) 588-594
60. Auburtin M., Wolff M., Charpentier J., Varon E., Le Tulzo Y., Girault C., et al. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 34 (2006) 2758-2765